IFS Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$785 Hold
58
﹤0.01% 205
2026
Q1
$347 Hold
58
﹤0.01% 208
2025
Q4
$415 Hold
58
﹤0.01% 182
2025
Q3
$619 Hold
58
﹤0.01% 164
2025
Q2
$561 Hold
58
﹤0.01% 156
2025
Q1
$863 Hold
58
﹤0.01% 180
2024
Q4
$865 Hold
58
﹤0.01% 166
2024
Q3
$1.11K Hold
58
﹤0.01% 134
2024
Q2
$1.2K Hold
58
﹤0.01% 130
2024
Q1
$1.09K Hold
58
﹤0.01% 128
2023
Q4
$836 Hold
58
﹤0.01% 129
2023
Q3
$1.01K Hold
58
﹤0.01% 122
2023
Q2
$1.21K Hold
58
﹤0.01% 119
2023
Q1
$1.36K Hold
58
0.01% 92
2022
Q4
$1.62K Hold
58
﹤0.01% 94
2022
Q3
$1K Hold
58
﹤0.01% 97
2022
Q2
$1K Hold
58
﹤0.01% 96
2022
Q1
$2K Hold
58
﹤0.01% 95
2021
Q4
$1K Buy
+58
New +$1.89K ﹤0.01% 112

Other funds holding OGN

IFS Advisors's OGN Position: Q2 2026 in Review

IFS Advisors held its Organon & Co (OGN) position steady in Q2 2026 at 58 shares worth $785. The position accounts for ﹤0.01% of the portfolio, ranked #205.

IFS Advisors first reported a position in OGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $2K in Q1 2022. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • IFS Advisors held 58 shares of Organon & Co worth $785 as of Q2 2026.
  • IFS Advisors left its Organon & Co share count unchanged in Q2 2026.
  • Organon & Co made up ﹤0.01% of IFS Advisors's portfolio in Q2 2026, its #205 holding.
  • IFS Advisors first reported a position in Organon & Co in Q4 2021 and has held it in 19 quarters since.
  • IFS Advisors's Organon & Co position peaked at $2K in Q1 2022.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on IFS Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.